Skip to content

Evaluation of a new portable test to identify patients with complex stroke

Asymmetrical Bioimpedance in the Anterior Circulation for Urgent Stratification of Stroke (ABACUS Stroke): a diagnostic accuracy study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN79169844
Enrollment
124
Registered
2018-09-11
Start date
2019-10-01
Completion date
Unknown
Last updated
2021-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Circulatory System Stroke, not specified as haemorrhage or infarction

Interventions

This research study is evaluating a new test which may help diagnose certain types of stroke. The new test is a non invasive device (called ‘Cerebrotech Visor System’) which measures changes in brain

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over 2. Transportation to the study hospital by ambulance 3. New stroke suspected by ambulance personnel before hospital arrival 4. At least responsive to tactile stimuli (i.e. A, V or P on the AVPU scale) on hospital arrival 5. Within 6 hours of last known well time or symptom onset time (hospital specialist judgement) 6. Brain imaging is intended to be or has been conducted within 60 minutes of hospital arrival 7. A CBA reading can be attempted +/- 30 minutes of the first brain imaging 8. The CBA reading will be within 6 hours of a hospital stroke specialist last known well time or symptom onset time

Exclusion criteria

Exclusion criteria: 1. Already assessed at another hospital and transfer to the regional neurosciences centre is for further investigation or treatment 2. Hypoglycaemia (capillary glucose < 3.5 mmol/l) 3. Presence of any known implanted electro-stimulating devices in the head and neck 4. Presence of any known metallic craniofacial implants, such as bone fixation plates or cranioplasty (aneurysm coils or clips, are acceptable) 5. Recent craniotomy or other reason known for the presence of intra-cranial air 6. Physical inability to wear the investigational device (e.g. skin lesions on scalp, haematomas) 7. Any other condition, which in the judgment of the stroke clinician might prevent the patient from tolerating CBA measurement or brain imaging (e.g. severe agitation or requiring immediate ITU admission)

Design outcomes

Primary

MeasureTime frame
1. The diagnostic accuracy of CBA measurement performed using the Cerebrotech Visor System to identify complex stroke in patients arriving at hospital with a paramedic assigned diagnosis of suspected stroke. Complex stroke is defined as ischaemic stroke caused by large vessel occlusion (LVO), or symptomatic severe anterior vessel stenosis, or haemorrhagic stroke =60 ml in volume, or previous territorial stroke. 2. The diagnostic accuracy of CBA measurement performed using the Cerebrotech Visor System to identify only ischaemic stroke caused by LVO in patients arriving at hospital with a paramedic assigned diagnosis of suspected acute stroke.

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026